NCT04471571

Brief Summary

The prevalence of molar incisor hypomineralization is relatively high. It has been reported that MIH-affected children experience a wide range of negative impacts because of having visible enamel opacities on their incisors whether these teeth show post eruptive breakdown or not. The management of MIH is challenging with a broad spectrum of treatment modalities being available. However, there are no clear guidelines available to aid in clinical decision making. Possible treatment options for anterior teeth with MIH include: Microabrasion, resin infiltration, tooth bleaching, etch-bleach and seal technique and composite restorations or veneers. It is believed that these methods could be used alone or in a combination of methods to achieve better aesthetic results. For MIH affected-incisors microabrasion and resin infiltration are acceptable treatment options which could be used alone or in a combination. Accordingly, the aim of this study is to compare the clinical outcomes of using resin infiltration either alone or combined with microabrasion for the management of MIH affected incisors.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2021

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 2, 2020

Completed
13 days until next milestone

First Posted

Study publicly available on registry

July 15, 2020

Completed
6 months until next milestone

Study Start

First participant enrolled

January 1, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2022

Completed
Last Updated

July 15, 2020

Status Verified

July 1, 2020

Enrollment Period

1 year

First QC Date

July 2, 2020

Last Update Submit

July 14, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in the aesthetics and amount of color masking of the lesion

    Vita Easyshade Advance® spectrophotometer (Vita Zahnfabrik, Sackingen, Germany) will be used to evaluate the change in color of the teeth selected in the study before and after the treatment. L\*, a\*, and b\* values will be recorded for each tooth based on the CIEL\*a\* b\* color space. The value of color differences or color masking (∆E) will be clinically evaluated by the formula ∆E=\[(∆L\*)2+(∆a\*)2+(∆b\*). Color readings will be taken before, immediately after, 1, 3, 6, and 12 months after treatment.

    12 months

Secondary Outcomes (1)

  • Change in the patient's oral health related quality of life following the treatment: Child Perceptions Questionnaire CPQ 8-10/11-14

    12 months

Study Arms (2)

Resin infiltration group

ACTIVE COMPARATOR

Enamel lesions for this group will be treated only by resin infiltration.

Other: Resin infiltration for MIH-affected incisors

Microabrasion + resin infiltration group

EXPERIMENTAL

Enamel lesions for this group will be treated first by microabrasion followed by resin infiltration.

Other: Resin infiltration and microabrasion for MIH-affected incisors

Interventions

MIH-affected incisors will be treated with microabrasion followed by resin infiltration as a combined treatment

Microabrasion + resin infiltration group

MIH-affected incisors will be treated with resin infiltration alone

Resin infiltration group

Eligibility Criteria

Age7 Years - 16 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Cooperative children aged between 7-16 years old
  • Children with MIH having enamel opacity involving at least one permanent incisor
  • MIH- affected incisors which did not receive any previous treatment
  • /3 of the crown should be visible in the oral cavity
  • Lesions size should be more than 1mm
  • Healthy children

You may not qualify if:

  • Children with systemic diseases, allergies or any dental or facial anomaly other than MIH
  • Children aged \< 7 or \> 16 years old
  • Uncooperative children
  • MIH patients without the affection of the incisors or with compromised incisor esthetics due to tooth surface loss, traumatic dental injury or caries
  • MIH incisors which already received any kind of treatment
  • Lesions which are smaller than 1mm in size

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Almuallem Z, Busuttil-Naudi A. Molar incisor hypomineralisation (MIH) - an overview. Br Dent J. 2018 Oct 5. doi: 10.1038/sj.bdj.2018.814. Online ahead of print.

    PMID: 30287963BACKGROUND
  • Hasmun N, Lawson J, Vettore MV, Elcock C, Zaitoun H, Rodd H. Change in Oral Health-Related Quality of Life Following Minimally Invasive Aesthetic Treatment for Children with Molar Incisor Hypomineralisation: A Prospective Study. Dent J (Basel). 2018 Nov 1;6(4):61. doi: 10.3390/dj6040061.

    PMID: 30388743BACKGROUND

MeSH Terms

Conditions

Molar Hypomineralization

Condition Hierarchy (Ancestors)

Dental Enamel HypomineralizationDevelopmental Defects of EnamelTooth AbnormalitiesStomatognathic System AbnormalitiesStomatognathic DiseasesTooth DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Shehab El-Din

    Cairo University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
Selection bias: will be overcome by randomization and allocation concealment. Performance bias: will be overcome by standardized method of application by single operator. Detection bias: will be overcome by blinding of the outcome assessor. Reporting bias: All the outcomes will be reported and published.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: two-arm parallel group randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant lecurer

Study Record Dates

First Submitted

July 2, 2020

First Posted

July 15, 2020

Study Start

January 1, 2021

Primary Completion

January 1, 2022

Study Completion

June 1, 2022

Last Updated

July 15, 2020

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share